Summary

The UK and GCC Biotech Procurement Market is projected to reach USD 5,213.51 million by 2035, expanding at a CAGR of 6.98% during 2025–2035. Growth is being driven by increasing investments in biotechnology research, pharmaceutical manufacturing, and advanced healthcare infrastructure across the UK and GCC countries.

Rising Biotechnology Research and Development Activities
The rapid progress in biotechnological areas like genomics, personalized medicine, and biopharmaceuticals is making the demand for laboratory equipment, consumables, and specialized procurement services soar, especially in the UK and the GCC. In addition, government-supported investments in life sciences and healthcare innovation are making procurement even more robust by facilitating the growth of cutting-edge research facilities and biotech production.

Market Segment Analysis
By Solutions
• Lab Procurement: Streamlines acquisition of critical laboratory materials.
• Equipment Maintenance: Reduces downtime through regular servicing support.
• Laboratory Services: Enhances research efficiency with specialized technical expertise.
By End User
• Biotech Organizations: Invest heavily in advanced research and development.
• Research Institutes: Sustain innovation through reliable laboratory procurement.
• CRO and CDMO: Support outsourced research and manufacturing activities.
• Others: Serve diverse biotechnology and life sciences applications.

Scientist.com Introduced AI-Powered Support Assistant "Aiden"
Scientist.com introduced Aiden in October 2024. This AI-based chatbot, developed on sophisticated large language model technology, is capable of supporting BioPharmCatalyst users at any time. The feature upgrades customer engagement by handling routine inquiries, helping users with platform tools, and providing investment insights that are customized.

Expanding Cross-Border Partnerships
Governments along with leading biotechnology companies and research institutions are working together which is opening up new procurement opportunities in the UK and GCC biotech markets. These alliances are not only facilitating technology transfer but also bolstering local manufacturing leading to increased demand for high-end laboratory instruments, biologics, and specialized procurement services.

Key Report Attributes
• Market Size 2035: USD 5,213.51 Million
• CAGR (2025-2035): 6.98%
• Base Year: 2024
• Market Forecast Period: 2025-2035

Industry Segmentations Growth
• By Solutions: Lab Procurement - 6.95%, Equipment Maintenance - 7.10%.
• By End User: Biotech Organizations - 7.18%, Research Institutes - 7.45%.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 16
1.1 OVERVIEW 16
1.2 MARKET ATTRACTIVENESS ANALYSIS 17
1.3 UK AND GCC BIOTECH PROCUREMENT MARKET, BY SOLUTIONS 18
1.4 UK AND GCC BIOTECH PROCUREMENT MARKET, BY END USER 19
1.5 UK AND GCC BIOTECH PROCUREMENT MARKET SIZE, BY COUNTRY 20
1.6 GCC BIOTECH PROCUREMENT MARKET, BY COUNTRY 21
2 MARKET INTRODUCTION 23
2.1 DEFINITION 23
2.2 SCOPE OF THE STUDY 23
2.3 RESEARCH OBJECTIVE 23
2.4 MARKET STRUCTURE 23
3 RESEARCH METHODOLOGY 24
3.1 OVERVIEW 24
3.2 DATA FLOW 26
3.2.1 DATA MINING PROCESS 26
3.3 PURCHASED DATABASE: 27
3.4 SECONDARY SOURCES: 28
3.4.1 SECONDARY RESEARCH DATA FLOW: 29
3.5 PRIMARY RESEARCH: 30
3.5.1 PRIMARY RESEARCH DATA FLOW: 31
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 32
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 32
3.6.1 REVENUE ANALYSIS APPROACH 32
3.7 DATA FORECASTING33
3.7.1 DATA FORECASTING TYPE 33
3.8 DATA MODELING 34
3.8.1 MICROECONOMIC FACTOR ANALYSIS: 34
3.8.2 DATA MODELING: 35
3.9 TEAMS AND ANALYST CONTRIBUTION 37
4 MARKET DYNAMICS 39
4.1 INTRODUCTION 39
4.2 DRIVERS 39
4.2.1 DEMAND FOR PRECISION MEDICINE AND BIOLOGICS 39
4.2.2 ADVANCEMENTS IN BIOTECHNOLOGY AND R&D INNOVATION 40
4.3 RESTRAINTS 41
4.3.1 ABSENCE OF SKILLED PROCUREMENT FUNCTION IN BIOTECH STARTUPS AND SMALL LABS 41
4.4 OPPORTUNITY 42
4.4.1 STRATEGIC PARTNERSHIPS AND INVESTMENTS 42
4.4.2 INTEGRATION OF ARTIFICIAL INTELLIGENCE IN BIOTECH PROCUREMENT PLATFORMS 43
4.5 IMPACT OF COVID-19 ON THE UK AND GCC BIOTECH PROCUREMENT MARKET 44
5 MARKET FACTOR ANALYSIS 45
5.1 SUPPLY CHAIN ANALYSIS 45
5.1.1 RAW MATERIAL SOURCING 45
5.1.2 MANUFACTURING & PRODUCTION 45
5.1.3 QUALITY CONTROL AND REGULATORY COMPLIANCE 45
5.1.4 PROCUREMENT & PLATFORM INTEGRATION 45
5.1.5 DISTRIBUTION & LOGISTICS 45
5.1.6 END-USER DELIVERY & AFTER-SALES SUPPORT 46
5.2 PORTER'S FIVE FORCES MODEL 46
5.2.1 THREAT OF NEW ENTRANTS 46
5.2.2 BARGAINING POWER OF SUPPLIERS 47
5.2.3 THREAT OF SUBSTITUTES 47
5.2.4 BARGAINING POWER OF BUYERS 47
5.2.5 INTENSITY OF RIVALRY 47
5.3 FINANCIAL ANALYSIS OF MAJOR PLAYERS 48
5.3.1 SUBSCRIPTION CHARGES 48
5.3.2 CUSTOMER ACQUISITION COST (CAC) 49
5.3.3 COMMISSION MODELS FOR SUPPLIERS 50
5.4 CURRENT MARKET TRENDS 51
5.4.1 DEMAND FOR CUSTOMIZABLE AND MODULAR PROCUREMENT PLATFORMS 51
5.4.2 SHIFT TOWARD LOCALIZATION AND ONSHORE MANUFACTURING 51
5.4.3 ADOPTION OF BLOCKCHAIN FOR TRACEABILITY AND TRANSPARENCY 52
5.5 LIST OF POTENTIAL CUSTOMERS 53
5.6 RECENT DEVELOPMENTS IN THE UK & GCC BIOTECH PROCUREMENT MARKET 55
5.7 QUALITATIVE ANALYSIS OF SUPPLIERS PAIN POINTS AND WILLINGNESS TO JOIN A NEW
BIOTECH PROCUREMENT PLATFORM 56
5.7.1 ANALYSIS OF SUPPLIERS WILLINGNESS TO JOIN BIOTECH PROCUREMENT PLATFORM 56
5.7.2 ANALYSIS OF SUPPLIERS PAIN POINT TO JOIN BIOTECH PROCUREMENT PLATFORM 56
5.8 QUALITATIVE ANALYSIS OF CUSTOMER PAIN POINTS AND WILLINGNESS TO JOIN A NEW
BIOTECH PROCUREMENT PLATFORM 57
5.8.1 CUSTOMER WILLINGNESS TO ADOPT BIOTECH PROCUREMENT PLATFORMS IN THE UK AND GCC REGIONS 57
5.8.2 ANALYSIS OF CUSTOMERS PAIN POINT TO JOIN BIOTECH PROCUREMENT PLATFORM 59
5.9 LIST OF MOST SOLD PRODUCTS IN GCC COUNTRIES 60
5.10 LIST OF POTENTIAL SUPPLIERS TO TARGET IN GCC 61
5.11 LIST OF MAJOR BIOTECH PROCUREMENT COMPANIES IN THE US 62
5.12 QUALITATIVE ANALYSIS OF EQUIPMENT MAINTENANCE AND LABORATORY SERVICE
PROVIDERS 64
6 UK AND GCC BIOTECH PROCUREMENT MARKET, BY SOLUTIONS 67
6.1 OVERVIEW 67
6.2 LAB PROCUREMENT 70
6.3 EQUIPMENT MAINTENANCE 70
6.4 LABORATORY SERVICES 71
7 UK AND GCC BIOTECH PROCUREMENT MARKET, BY END USER 72
7.1 OVERVIEW 72
7.2 BIOTECH ORGANIZATIONS 75
7.3 RESEARCH INSTITUTES 76
7.4 CRO AND CDMO 76
7.5 OTHERS 76
8 UK AND GCC BIOTECH PROCUREMENT MARKET, BY COUNTRY 77
8.1 OVERVIEW 77
8.2 UK 78
8.3 GCC COUNTRIES 81
8.3.1 SAUDI ARABIA 85
8.3.2 UAE 86
8.3.3 REST OF GCC COUNTRIES 88
9 COMPETITIVE LANDSCAPE 91
9.1 INTRODUCTION 91
9.2 UK MARKET SHARE ANALYSIS, 2024 91
9.3 GCC MARKET SHARE ANALYSIS, 2024 92
9.4 COMPETITOR DASHBOARD93
9.5 PUBLIC PLAYERS STOCK SUMMARY 94
9.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL 94
9.1 KEY DEVELOPMENTS & GROWTH STRATEGIES 94
9.1.1 PRODUCT LAUNCH 94
9.1.2 PLATFORM LAUNCH 95
9.1.3 SERVICE LAUNCH 95
9.1.4 PARTNERSHIP 96
9.1.5 RECOGNITION 97
10 COMPANY PROFILES 98
10.1 THERMO FISHER SCIENTIFIC INC. 98
10.1.1 COMPANY OVERVIEW 98
10.1.2 FINANCIAL OVERVIEW 99
10.1.3 PRODUCTS/SERVICES OFFERED 100
10.1.4 KEY DEVELOPMENTS 100
10.1.5 SWOT ANALYSIS 100
10.1.6 KEY STRATEGIES 101
10.2 AMICI PROCUREMENT LTD. 102
10.2.1 COMPANY OVERVIEW 102
10.2.2 FINANCIAL OVERVIEW102
10.2.3 PRODUCTS/SERVICES OFFERED 103
10.2.4 KEY DEVELOPMENTS 103
10.2.5 SWOT ANALYSIS 103
10.2.6 KEY STRATEGIES 104
10.3 ZAGENO 105
10.3.1 COMPANY OVERVIEW 105
10.3.2 FINANCIAL OVERVIEW106
10.3.3 PRODUCTS/SERVICES OFFERED 106
10.3.4 KEY DEVELOPMENTS 106
10.3.5 SWOT ANALYSIS 107
10.3.6 KEY STRATEGIES 107
10.4 PRENDIO 108
10.4.1 COMPANY OVERVIEW 108
10.4.2 FINANCIAL OVERVIEW108
10.4.3 PRODUCTS/SERVICES OFFERED 109
10.4.4 KEY DEVELOPMENTS 109
10.4.5 KEY STRATEGIES 110
10.5 QUARTZY INC. 111
10.5.1 COMPANY OVERVIEW 111
10.5.2 FINANCIAL OVERVIEW111
10.5.3 PRODUCTS/SERVICES OFFERED 112
10.5.4 KEY DEVELOPMENTS 112
10.5.5 KEY STRATEGIES 112
10.6 SCIENTIST.COM 113
10.6.1 COMPANY OVERVIEW 113
10.6.2 FINANCIAL OVERVIEW 114
10.6.3 SERVICES/PRODUCTS OFFERED 114
10.6.4 KEY DEVELOPMENTS 115
10.6.5 KEY STRATEGIES 116
10.7 COUPA SOFTWARE INC117
10.7.1 COMPANY OVERVIEW 117
10.7.2 FINANCIAL OVERVIEW 118
10.7.3 SERVICES/PRODUCTS OFFERED 118
10.7.4 KEY DEVELOPMENTS 118
10.7.5 SWOT ANALYSIS 119
10.7.6 KEY STRATEGIES 119
10.8 PRECORO INC 120
10.8.1 COMPANY OVERVIEW 120
10.8.2 FINANCIAL OVERVIEW 121
10.8.3 SERVICES/PRODUCTS OFFERED 121
10.8.4 KEY DEVELOPMENTS 121
10.8.5 KEY STRATEGIES 122
10.9 EYVO INC 123
10.9.1 COMPANY OVERVIEW 123
10.9.2 FINANCIAL OVERVIEW 124
10.9.3 SERVICES/PRODUCTS OFFERED 124
10.9.4 KEY DEVELOPMENTS 124
10.9.5 KEY STRATEGIES 124
10.10 AVANTOR INC 125
10.10.1 COMPANY OVERVIEW 125
10.10.2 FINANCIAL OVERVIEW 126
10.10.3 SERVICES/PRODUCTS OFFERED 127
10.10.4 KEY DEVELOPMENTS 127
10.10.5 SWOT ANALYSIS 128
10.10.6 KEY STRATEGIES 128
11 DATA CITATIONS 129

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 36
TABLE 2 SUBSCRIPTION CHARGES BY MAJOR PLAYERS 48
TABLE 3 CUSTOMER ACQUISITION COST (CAC) FOR MAJOR PLAYERS 49
TABLE 4 LIST OF POTENTIAL CUSTOMERS IN THE UK 53
TABLE 5 LIST OF POTENTIAL CUSTOMERS IN UAE AND SAUDI ARABIA 54
TABLE 6 LIST OF MOST SOLD PRODUCT IN GCC COUNTRIES 60
TABLE 7 LIST OF POTENTIAL SUPPLIER IN GCC 61
TABLE 8 LIST OF MAJOR BIOTECH PROCUREMENT COMPANIES IN THE US 62
TABLE 9 UK AND GCC BIOTECH PROCUREMENT MARKET, BY SOLUTIONS, 2019–2035 (USD MILLION) 69
TABLE 10 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR LAB PROCUREMENT, BY TYPE, 2019–2035 (USD MILLION) 70
TABLE 11 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR LAB PROCUREMENT, BY COUNTRY, 2019–2035 (USD MILLION) 70
TABLE 12 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR EQUIPMENT MAINTENANCE, BY COUNTRY, 2019–2035 (USD MILLION) 70
TABLE 13 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019–2035 (USD MILLION) 71
TABLE 14 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR LABORATORY SERVICES, BY COUNTRY, 2019–2035 (USD MILLION) 71
TABLE 15 UK AND GCC BIOTECH PROCUREMENT MARKET, BY END USER, 2019–2035 (USD MILLION) 74
TABLE 16 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR BIOTECH ORGANIZATIONS, BY COUNTRY, 2019–2035 (USD MILLION) 75
TABLE 17 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR RESEARCH INSTITUTES, BY COUNTRY, 2019–2035 (USD MILLION) 76
TABLE 18 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR CRO AND CDMO, BY COUNTRY, 2019–2035 (USD MILLION) 76
TABLE 19 UK AND GCC BIOTECH PROCUREMENT MARKET, FOR OTHERS, BY COUNTRY, 2019–2035 (USD MILLION) 76
TABLE 20 UK AND GCC BIOTECH PROCUREMENT MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 77
TABLE 21 UK: BIOTECH PROCUREMENT MARKET, BY SOLUTIONS, 2019–2035 (USD MILLION) 79
TABLE 22 UK: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LAB PROCUREMENT, 2019–2035 (USD MILLION) 80
TABLE 23 UK: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LABORATORY SERVICES, 2019–2035 (USD MILLION) 80
TABLE 24 UK: BIOTECH PROCUREMENT MARKET, BY END USERS, 2019–2035 (USD MILLION) 80
TABLE 25 GCC COUNTRIES: BIOTECH PROCUREMENT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 82
TABLE 26 GCC COUNTRIES: BIOTECH PROCUREMENT MARKET, BY SOLUTIONS, 2019–2035 (USD MILLION) 83
TABLE 27 GCC COUNTRIES: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LAB PROCUREMENT, 2019–2035 (USD MILLION) 83
TABLE 28 GCC COUNTRIES: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LABORATORY SERVICES, 2019–2035 (USD MILLION) 84
TABLE 29 GCC COUNTRIES: BIOTECH PROCUREMENT MARKET, BY END USERS, 2019–2035 (USD MILLION) 84
TABLE 30 SAUDI ARABIA: BIOTECH PROCUREMENT MARKET, BY SOLUTIONS, 2019–2035 (USD MILLION) 85
TABLE 31 SAUDI ARABIA: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LAB PROCUREMENT, 2019–2035 (USD MILLION) 85
TABLE 32 SAUDI ARABIA: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LABORATORY SERVICES, 2019–2035 (USD MILLION) 85
TABLE 33 SAUDI ARABIA: BIOTECH PROCUREMENT MARKET, BY END USERS, 2019–2035 (USD MILLION) 86
TABLE 34 UAE: BIOTECH PROCUREMENT MARKET, BY SOLUTIONS, 2019–2035 (USD MILLION) 86
TABLE 35 UAE: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LAB PROCUREMENT, 2019–2035 (USD MILLION) 86
TABLE 36 UAE: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LABORATORY SERVICES, 2019–2035 (USD MILLION) 87
TABLE 37 UAE: BIOTECH PROCUREMENT MARKET, BY END USERS, 2019–2035 (USD MILLION) 87
TABLE 38 UAE: BIOTECH PROCUREMENT MARKET, BY SOLUTIONS, 2019–2035 (USD MILLION) 88
TABLE 39 UAE: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LAB PROCUREMENT, 2019–2035 (USD MILLION) 88
TABLE 40 UAE: BIOTECH PROCUREMENT MARKET, FOR SOLUTIONS, BY LABORATORY SERVICES, 2019–2035 (USD MILLION) 88
TABLE 41 UAE: BIOTECH PROCUREMENT MARKET, BY END USERS, 2019–2035 (USD MILLION) 89
TABLE 42 PRODUCT LAUNCH 94
TABLE 43 PLATFORM LAUNCH 95
TABLE 44 SERVICE LAUNCH 95
TABLE 45 PARTNERSHIP 96
TABLE 46 RECOGNITION 97
TABLE 47 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 100
TABLE 48 AMICI PROCUREMENT LTD.: PRODUCTS/SERVICES OFFERED 103
TABLE 49 ZAGENO: PRODUCTS/SERVICES OFFERED 106
TABLE 50 ZAGENO: KEY DEVELOPMENTS 106
TABLE 51 PRENDIO: PRODUCTS/SERVICES OFFERED 109
TABLE 52 PRENDIO: KEY DEVELOPMENTS 109
TABLE 53 QUARTZY INC.: PRODUCTS/SERVICES OFFERED 112
TABLE 54 QUARTZY INC.: KEY DEVELOPMENTS 112
TABLE 55 SCIENTIST: SERVICES/PRODUCTS OFFERED 114
TABLE 56 SCIENTIST: KEY DEVELOPMENTS 115
TABLE 57 COUPA SOFTWARE INC: SERVICES/PRODUCTS OFFERED 118
TABLE 58 COUPA SOFTWARE INC: KEY DEVELOPMENTS 118
TABLE 59 PRECORO INC: SERVICES/PRODUCTS OFFERED 121
TABLE 60 PRECORO INC: KEY DEVELOPMENTS 121
TABLE 61 EYVO INC: SERVICES/PRODUCTS OFFERED 124
TABLE 62 AVANTOR INC: SERVICES/PRODUCTS OFFERED 127LIST OF FIGURES
FIGURE 1 MARKET ATTRACTIVENESS ANALYSIS: UK AND GCC BIOTECH PROCUREMENT MARKET, 2024 17
FIGURE 2 UK AND GCC BIOTECH PROCUREMENT MARKET ANALYSIS, BY SOLUTIONS, 2024 18
FIGURE 3 UK AND GCC BIOTECH PROCUREMENT ANALYSIS, BY END USER, 2024 19
FIGURE 4 UK AND GCC BIOTECH PROCUREMENT MARKET SIZE ANALYSIS, BY COUNTRY, 2024 20
FIGURE 5 GCC BIOTECH PROCUREMENT ANALYSIS, BY COUNTRY, 2024 21
FIGURE 1 UK AND GCC BIOTECH PROCUREMENT MARKET: STRUCTURE 23
FIGURE 2 UK AND GCC BIOTECH PROCUREMENT MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035) 39
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2035) 41
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2035) 42
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: UK AND GCC BIOTECH PROCUREMENT MARKET 46
FIGURE 6 UK AND GCC BIOTECH PROCUREMENT MARKET, SOLUTIONS SEGMENT ATTRACTIVENESS, 2019-2035 (USD MILLION) 68
FIGURE 7 UK AND GCC BIOTECH PROCUREMENT MARKET, BY SOLUTIONS, 2024 & 2035 (USD MILLION) 68
FIGURE 8 UK AND GCC BIOTECH PROCUREMENT MARKET SHARE (%), BY SOLUTIONS, 2024 69
FIGURE 9 UK AND GCC BIOTECH PROCUREMENT MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2035 (USD MILLION) 73
FIGURE 10 UK AND GCC BIOTECH PROCUREMENT MARKET, BY END USER, 2024 & 2035 (USD MILLION) 74
FIGURE 11 UK AND GCC BIOTECH PROCUREMENT MARKET SHARE (%), BY END USER, 2024 75
FIGURE 12 UK AND GCC BIOTECH PROCUREMENT MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 77
FIGURE 13 UK AND GCC BIOTECH PROCUREMENT MARKET SIZE, SHARE (%), BY COUNTRY, 2024 78
FIGURE 14 UK MARKET ANALYSIS: BIOTECH PROCUREMENT MARKET, 2019-2035 79
FIGURE 15 GCC COUNTRIES MARKET ANALYSIS: BIOTECH PROCUREMENT MARKET, 2019-2035 81
FIGURE 16 GCC COUNTRIES: BIOTECH PROCUREMENT MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 82
FIGURE 17 GCC COUNTRIES: BIOTECH PROCUREMENT MARKET SIZE, SHARE (%), BY COUNTRY, 2024 83
FIGURE 18 UK BIOTECH PROCUREMENT MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 91
FIGURE 19 GCC BIOTECH PROCUREMENT MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 92
FIGURE 20 COMPETITOR DASHBOARD: UK AND GCC BIOTECH PROCUREMENT MARKET 93
FIGURE 21 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 99
FIGURE 22 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 100
FIGURE 23 AMICI PROCUREMENT LTD.: SWOT ANALYSIS 103
FIGURE 24 ZAGENO: SWOT ANALYSIS 107
FIGURE 25 COUPA SOFTWARE INC: SWOT ANALYSIS 119
FIGURE 26 AVANTOR INC: FINANCIAL OVERVIEW SNAPSHOT 126
FIGURE 27 AVANTOR INC: SWOT ANALYSIS 128